GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-0.18 Cr | ₹-0.23 Cr | ₹-0.14 Cr | ₹0.00 Cr | ₹0.15 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of GENNEX LABORATORIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-0.18 Cr |
| Mar2024 | ₹-0.23 Cr |
| Mar2023 | ₹-0.14 Cr |
| Mar2022 | ₹0.00 Cr |
| Mar2021 | ₹0.15 Cr |
How is Deferred Tax Assets / Liabilities of GENNEX LABORATORIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.18 Cr | Negative | |
| Mar2024 | ₹-0.23 Cr | Negative | |
| Mar2023 | ₹-0.14 Cr | Negative | |
| Mar2022 | ₹0.00 Cr | -98.04 | |
| Mar2021 | ₹0.15 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹268.2 Cr | -7.5% | 24.6% | 0.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -1.8% | -3.7% | 17.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 3.4% | 10.1% | 57.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.6% | 0.8% | 37.8% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -0.4% | -5.6% | -11.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | -1.1% | -4.9% | -9.9% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -7.5% |
24.6% |
0.7% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses